These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6523910)

  • 1. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD; Neumann J
    Z Arztl Fortbild (Jena); 1984; 78(20):853-6. PubMed ID: 6523910
    [No Abstract]   [Full Text] [Related]  

  • 2. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is there a special indication for fluphenazine in therapy refractory hallucinations?].
    Bechter K
    Nervenarzt; 1994 Nov; 65(11):798-801. PubMed ID: 7816159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience with fluphenazine Depot].
    Vencovský E; Sedivec V; Peterová E; Baudis P; Dvoráková M
    Act Nerv Super (Praha); 1970 Jan; 12(1):49-50. PubMed ID: 5418656
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT; Hoerdt HP
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate].
    Berliner J
    Acta Psychiatr Belg; 1974 May; 74(3):305-16. PubMed ID: 4455024
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic effect of buprenorphine in schizophrenia.
    Schmauss C; Yassouridis A; Emrich HM
    Am J Psychiatry; 1987 Oct; 144(10):1340-2. PubMed ID: 3310672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
    Mamo DC; Sweet RA; Chengappa KN; Reddy RR; Jeste DV
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.
    Gaby N; Lefkowitz D; Israel JR
    N C Med J; 1982 Sep; 43(9):641-4. PubMed ID: 6958987
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experience with fluphenazine decanoate in psychoses].
    Náhunek K; Rodová A; Svestka J
    Act Nerv Super (Praha); 1970 Jan; 12(1):47-9. PubMed ID: 5460564
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
    Balon R; Kabesh Ia; Papezhova G
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-action neuroleptic agents (delayed-action neuroleptics)].
    Ginestet D; Péron-Magnan P
    Rev Prat; 1972 Apr; 22(12):1941-53. PubMed ID: 4675045
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
    Brown WA; Silver MA
    J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with a new depot neuroleptic].
    Christiani K
    Med Klin; 1969 Sep; 64(39):1761-2. PubMed ID: 5346114
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical observations on treatment with flufenazin dihydrochloride (Lyorodin--Jenapharm)].
    Chiriţă V; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(4):695-8. PubMed ID: 2636770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary].
    Abramova LI; Gushanskiĭ EL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):419-24. PubMed ID: 3705854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
    Polácek J
    Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of a mild form of neuroleptic malignant syndrome with oral diazepam.
    Kontaxakis VP; Christodoulou GN; Markidis MP; Havaki-Kontaxaki BJ
    Acta Psychiatr Scand; 1988 Sep; 78(3):396-8. PubMed ID: 3195360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.